FrancophonIA/ELRC3.0 huggingface dataset:
English: If you suffer from any of the following illnesses tell your doctor as soon as possible: ─ Stroke or “mini” stroke (temporary symptoms of stroke) ─ Parkinson's disease ─ Prostate problems ─ A blocked intestine (Paralytic ileus) ─ Liver or kidney disease ─ Blood disorders ─ Heart disease ─ Diabetes ─ Seizures ─ If you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting (being sick) or usage of diuretics (water tablets)
Croatian: Ako bolujete od bilo koje od sljedećih bolesti, obavijestite svojeg liječnika što je prije moguće: - Moždani udar ili “mali” moždani udar (kratkotrajni simptomi moždanog udara) - Parkinsonova bolest - Tegobe s prostatom - Zatvor crijeva (paralitički ileus) - Bolest jetre ili bubrega - Poremećaji krvi - Bolest srca - Šećerna bolest - Napadaji
English: Your doctor should do blood tests to check blood sugar and certain fat levels before you start taking Zalasta and regularly during treatment.
Croatian: Prije početka uzimanja Zalaste te redovito tijekom liječenja, liječnik bi Vam trebao obaviti krvne pretrage kako bi provjerio razinu šećera i određenih masnoća u krvi.
English: Microcrystalline cellulose Crospovidone
Croatian: Celuloza, mikrokristalična Krospovidon
English: Adverse event identified from clinical trials in the Olanzapine Integrated Database.
Croatian: Nuspojava je identificirana iz kliničkih ispitivanja u integriranoj bazi podataka za olanzapin.
English: In female versus male subjects the mean elimination half life was somewhat prolonged (36.7 versus 32.3 hr) and the clearance was reduced (18.9 versus 27.3 l/hr).
Croatian: U žena je prosječno poluvrijeme eliminacije nešto duže u odnosu na muškarce (36,7 u odnosu na 32,3 sata), a klirens je smanjen (18,9 u odnosu na 27,3 l/sat).
English: • blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people) especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing.
Croatian: osoba), posebno u nogama (simptomi uključuju oticanje, bol i crvenilo nogu), koji može putovati krvnim žilama do pluća uzrokujući bol u prsima i otežano disanje.
English: Rare side effects (may affect up to 1 in 1000 people) include lowering of normal body temperature; abnormal rhythms of the heart; sudden unexplained death; inflammation of the pancreas causing severe stomach pain, fever and sickness; liver disease appearing as yellowing of the skin and white parts of the eyes; muscle disease presenting as unexplained aches and pains; and prolonged and/or painful erection.
Croatian: Rijetke nuspojave (mogu se javiti u najviše 1 na 1000 osoba) uključuju sniženje normalne tjelesne temperature; poremećaj rada srca; naglu neobjašnjivu smrt; upalu gušterače koja uzrokuje jaku bol u trbuhu, vrućicu i mučninu; bolest jetre koja se očituje žutilom kože i bjeloočnica; bolest mišića koja se manifestira neobjašnjivim bolovima; te produžena i/ili bolna erekcija.
English: Each orodispersible tablet contains 5 mg, 7.5 mg, 10 mg, 15 mg or 20 mg olanzapine.
Croatian: Svaka raspadljiva tableta za usta sadrži 5 mg, 7,5 mg, 10 mg, 15 mg ili 20 mg olanzapina.
English: Musculoskeletal and connective tissue disorders Arthralgia
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva Artralgija
English: Urinary incontinence, urinary retention Urinary hesitation
Croatian: Poremećaji bubrega i mokraćnog sustava Urinarna inkontinencija, urinarna retencija
English: Zalasta 7.5 mg tablets Each tablet contains 121.3 mg lactose.
Croatian: Zalasta 7,5 mg tablete Svaka tableta sadrži 121,3 mg laktoze.
English: In non-smoking versus smoking subjects (males and females) the mean elimination half-life was prolonged (38.6 versus 30.4 hr) and the clearance was reduced (18.6 versus 27.7 l/hr).
Croatian: Prosječno poluvrijeme eliminacije u ispitanika nepušača (muškarci i žene) bilo je duže nego u ispitanika pušača (38,6 u odnosu na 30,4 sata), a klirens je bio manji (18,6 u odnosu na 27,7 l/sat).
English: orodispersible tablet
Croatian: raspadljiva tableta za usta
English: Patients gaining ≥ 7 %, ≥ 15 % and ≥ 25 % of their baseline body weight with long-term exposure (at least 48 weeks) were very common (64.4 %, 31.7 % and 12.3 % respectively).
Croatian: Tijekom dugotrajne izloženosti lijeku (najmanje 48 tjedana), povećanje tjelesne težine ≥ 7%, ≥ 15% i ≥ 25% od početne bilo je vrlo često (64,4%, 31,7%, odnosno 12,3%).
English: Seizures have been reported to occur uncommonly in patients when treated with olanzapine.
Croatian: Zabilježeno je da se konvulzije manje često pojavljuju u bolesnika liječenih olanzapinom.
English: Lactose monohydrate Powdered cellulose Pregelatinised maize starch Maize starch
Croatian: Kukuruzni škrob, prethodno geliran Kukuruzni škrob
English: There is a risk of feeling drowsy when you are given Zalasta.
Croatian: Tijekom uzimanja Zalaste postoji rizik da se osjećate pospano.
English: Zalasta 2.5 mg tablets Each tablet contains 40.4 mg lactose.
Croatian: Zalasta 2,5 mg tablete Svaka tableta sadrži 40,4 mg laktoze.
English: Gynaecomastia/breast enlargement in males
Croatian: Ginekomastija/po većanje dojki u muškaraca
English: Uncommon side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g. swelling in the mouth and throat, itching, rash); diabetes or the worsening of diabetes, occasionally associated with ketoacidosis (ketones in the blood and urine) or coma; seizures, usually associated with a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; problems with speech; stuttering; slow heart rate; sensitivity to sunlight; bleeding from the nose; abdominal distension; memory loss or forgetfulness; urinary incontinence; lack of ability to urinate; hair loss; absence or decrease in menstrual periods; and changes in breasts in males and females such as an abnormal production of breast milk or abnormal growth.
Croatian: Manje česte nuspojave (mogu se javiti u manje od 1 na 100 osoba) uključuju preosjetljivost (npr. oticanje u ustima i grlu, svrbež; osip); šećernu bolest ili pogoršanje šećerne bolesti, ponekad povezano s ketoacidozom (ketonima u krvi i mokraći) ili komom; napadaje, obično povezane s napadajima u povijesti bolesti (epilepsija); mišićnu ukočenost ili grč (uključujući pokrete očiju); sindrom nemirnih nogu; poteškoće s govorom; mucanje; usporeni rad srca; osjetljivost na sunčevu svjetlost; krvarenje iz nosa; nadimanje trbuha; gubitak pamćenja ili zaboravljivost; nemogućnost zadržavanja mokraće (inkontinencija); nemogućnost mokrenja; ispadanje kose; izostanak ili smanjenje menstruacija i promjene na grudima u muškaraca i žena, kao što je poremećaj stvaranja majčinog mlijeka ili abnormalan rast.
English: In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulted in an incidence of neutropenia of 4.1%; a potential contributing factor could be high plasma valproate levels.
Croatian: U jednom kliničkom ispitivanju u bolesnika s bipolarnom manijom, kombinacijska terapija valproata i olanzapina uzrokovala je pojavu neutropenije od 4,1%.
English: Investigations Elevated plasma prolactin levels
Croatian: Povišene razine prolaktina u plazmi
English: ─ High blood sugar and high levels of fat (triglycerides and cholesterol) have been seen in patients taking Zalasta.
Croatian: - U bolesnika koji uzimaju Zalastu uočena je visoka razina šećera i masnoća u krvi (trigliceridi i kolesterol).
English: The mean increase in olanzapine AUC was 52% and 108% respectively.
Croatian: Prosječni porast AUC olanzapina iznosio je 52% u žena nepušača, odnosno 108% u muškaraca pušača.
English: Transient, asymptomatic elevations of hepatic aminotransferases, ALT, AST have been seen commonly, especially in early treatment.
Croatian: Često je uočen prolazni asimptomatski porast vrijednosti jetrenih aminotransferaza, alanin transferaze (ALT) i aspartat transferaze (AST), osobito u ranoj fazi liječenja.
English: Zalasta 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg orodispersible tablets: available in boxes of 14, 28, 35, 56 and 70 tablets in blisters.
Croatian: Zalasta raspadljive tablete za usta od 5 mg, 7,5 mg, 10 mg, 15 mg i 20 mg: dostupne su u kutijama od 14, 28, 35, 56 i 70 tableta u blisterima.
English: Zalasta 20 mg tablets EU/1/07/415/027-031
Croatian: Zalasta 20 mg tablete EU/1/07/415/027-031
English: Colloidal anhydrous silica Magnesium stearate
Croatian: Silicijev dioksid, koloidni, bezvodni Magnezijev stearat
English: What Zalasta looks like and contents of the pack Zalasta 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg orodispersible tablets are: round, slightly biconvex, yellow marbled tablets with possible individual spots.
Croatian: Zalasta raspadljive tablete za usta od 5 mg, 7,5 mg, 10 mg, 15 mg i 20 mg su: okrugle, blago bikonveksne, žuto mramorirane tablete s mogućim pojedinačnim mrljama.
English: Other medicines and Zalasta
Croatian: Drugi lijekovi i Zalasta
English: Dizziness Akathisia Parkinsonism Dyskinesia
Croatian: Omaglica Akatizija Parkinsonizam Diskinezija
English: 14 orodispersible tablets 28 orodispersible tablets 35 orodispersible tablets 56 orodispersible tablets 70 orodispersible tablets
Croatian: 14 raspadljivih tableta za usta 28 raspadljivih tableta za usta 35 raspadljivih tableta za usta 56 raspadljivih tableta za usta 70 raspadljivih tableta za usta
English: Zalasta 10 mg tablets Each tablet contains 161.8 mg lactose.
Croatian: Svaka tableta sadrži 161,8 mg laktoze.
English: Zalasta 20 mg tablets
Croatian: Zalasta 20 mg tablete
English: This medicine contains 0.75 mg aspartame in each 7.5 mg orodispersible tablet.
Croatian: Ovaj lijek sadrži 0,75 mg aspartama u svakoj 7,5 mg raspadljivoj tableti za usta.
English: Drug withdrawal syndrome neonatal (see section 4.6)
Croatian: Sindrom ustezanja u novorođenčadi (vidjeti dio 4.6)
English: Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Croatian: Česte nuspojave (mogu se javiti u manje od 1 na 10 osoba) uključuju promjene razina nekih krvnih stanica, cirkulirajućih masti u krvi te, u ranim fazama liječenja, privremena povećanja razine jetrenih enzima; povišene razine šećera u krvi i mokraći; povećanje razine mokraćne kiseline i kreatin fosfokinaze u krvi; pojačan apetit; omaglicu; nemir; nevoljno drhtanje; neuobičajene pokrete (diskinezije); zatvor; suha usta; osip; slabost; pojačani umor; zadržavanje vode u tijelu koje dovodi do otečenosti ruku, zglobova ili stopala te seksualni poremećaji kao što su smanjenje libida u muškaraca i žena ili erektilne disfunkcije u muškaraca.
English: Zalasta 15 mg tablets EU/1/07/415/022-026
Croatian: Zalasta 15 mg tablete EU/1/07/415/022-026
English: Vascular disorders Orthostatic hypotension
Croatian: Krvožilni poremećaji Ortostatska hipotenzija
English: Zalasta 7.5 mg tablets
Croatian: Zalasta 7,5 mg tablete
English: Zalasta 5 mg tablets EU/1/07/415/006-010
Croatian: Zalasta 5 mg tablete EU/1/07/415/006-010
English: If this happens after you have been given Zalasta tell your doctor.
Croatian: Vam se ovo pojavi nakon uzimanja Zalaste, obratite se svom liječniku.
English: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia KRKA-POLSKA Sp. z o.o., ul.
Croatian: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija KRKA-POLSKA
English: How to take Zalasta
Croatian: Kako uzimati Zalastu
English: Restless legs syndrome
Croatian: Sindrom nemirnih nogu
English: Adverse event identified from spontaneous post-marketing reporting with frequency determined utilising the Olanzapine Integrated Database.
Croatian: Nuspojava je identificirana iz spontanih prijava nakon stavljanja lijeka u promet, a učestalost je određena uz pomoć integrirane baze podataka za olanzapin.
English: Only take other medicines while you are on Zalasta if your doctor tells you that you can. You might feel drowsy if Zalasta is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).
Croatian: Ako uzimate Zalastu u kombinaciji s antidepresivima ili lijekovima za tjeskobu ili lijekovima koji Vam pomažu zaspati (trankvilizeri), možete se osjećati pospano.
English: Zalasta 2.5 mg tablets EU/1/07/415/001-005
Croatian: Zalasta 2,5 mg tablete EU/1/07/415/001-005
English: Zalasta contains lactose
Croatian: Zalasta sadrži laktozu
English: Zalasta 7.5 mg tablets EU/1/07/415/011-015
Croatian: Zalasta 7,5 mg tablete EU/1/07/415/011-015
English: This medicine contains 2.00 mg aspartame in each 20 mg orodispersible tablet.
Croatian: Ovaj lijek sadrži 2,00 mg aspartama u svakoj 20 mg raspadljivoj tableti za usta.
English: Zalasta 7.5 mg orodispersible tablets Each orodispersible tablet contains 0.75 mg aspartame.
Croatian: Zalasta 7,5 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 0,75 mg aspartama.
English: Zalasta 2.5 mg tablets
Croatian: Zalasta 2,5 mg tablete
English: Changes in fasting triglycerides from borderline at baseline (≥ 1.69 mmol/l-< 2.26 mmol/l) to high (≥ 2.26 mmol/l) were very common.
Croatian: (≥ 1,69 -< 2,26 mmol/l) do visokih vrijednosti (≥ 2,26 mmol/l) bile su vrlo česte.
English: This medicine contains 1.50 mg aspartame in each 15 mg orodispersible tablet.
Croatian: Ovaj lijek sadrži 1,50 mg aspartama u svakoj 15 mg raspadljivoj tableti za usta.
English: Zalasta 7.5 mg tablets Each tablet contains 7.5 mg olanzapine.
Croatian: Zalasta 7,5 mg tablete Svaka tableta sadrži 7,5 mg olanzapina.
English: ─ Weight gain has been seen in patients taking Zalasta.
Croatian: - Zapaženo je povećanje tjelesne težine u bolesnika koji uzimaju Zalastu.
English: Observed for fasting normal levels at baseline (< 1.69 mmol/l) which increased to high (≥ 2.26 mmol/l).
Croatian: Uočeno za početne normalne razine natašte (< 1,69 mmol/l) koje su porasle na visoke razine
English: Zalasta 10 mg tablets
Croatian: Zalasta 10 mg tablete
English: Zalasta 15 mg tablets
Croatian: Zalasta 15 mg tablete
English: This medicine contains 1.00 mg aspartame in each 10 mg orodispersible tablet.
Croatian: Ovaj lijek sadrži 1,00 mg aspartama u svakoj 10 mg raspadljivoj tableti za usta.
English: Zalasta 10 mg orodispersible tablets Each orodispersible tablet contains 1.00 mg aspartame.
Croatian: Zalasta 10 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 1,00 mg aspartama.
English: Zalasta 20 mg orodispersible tablets Each orodispersible tablet contains 20 mg olanzapine.
Croatian: Zalasta 20 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 20 mg olanzapina.
English: Zalasta 20 mg tablets Olanzapine
Croatian: Zalasta 20 mg tablete olanzapin
English: ─ The use of Zalasta in elderly patients with dementia is not recommended as it may have serious side effects ─ Medicines of this type may cause unusual movements mainly of the face or tongue.
Croatian: - Lijekovi ove vrste mogu uzrokovati pojavu neuobičajenih pokreta, uglavnom lica ili jezika.
English: Zalasta 15 mg orodispersible tablets Each orodispersible tablet contains 1.50 mg aspartame.
Croatian: Zalasta 15 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 1,50 mg aspartama.
English: Each tablet contains 2.5 mg olanzapine.
Croatian: Svaka tableta sadrži 2,5 mg olanzapina.
English: Each tablet contains 7.5 mg olanzapine.
Croatian: Svaka tableta sadrži 7,5 mg olanzapina.
English: Zalasta 5 mg tablets
Croatian: Zalasta 5 mg tablete
English: Zalasta 20 mg orodispersible tablets Each orodispersible tablet contains 2.00 mg aspartame.
Croatian: Zalasta 20 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 2,00 mg aspartama.
English: Zalasta 7.5 mg tablets Olanzapine
Croatian: Zalasta 7,5 mg tablete olanzapin
English: Each tablet contains 20 mg olanzapine.
Croatian: Svaka tableta sadrži 20 mg olanzapina.
English: Zalasta 2.5 mg tablets Each tablet contains 2.5 mg olanzapine.
Croatian: Zalasta 2,5 mg tablete Svaka tableta sadrži 2,5 mg olanzapina.
English: Glucosuria Increased appetite
Croatian: , povećani apetit
English: BLISTER FOR ZALASTA 20 mg TABLETS
Croatian: BLISTER ZA ZALASTA 20 mg TABLETE
English: Zalasta 5 mg orodispersible tablets Each orodispersible tablet contains 0.50 mg aspartame.
Croatian: Zalasta 5 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 0,50 mg aspartama.
English: Respiratory, thoracic and mediastinal disorders
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja Epistaksa
English: This medicine contains 0.50 mg aspartame in each 5 mg orodispersible tablet.
Croatian: Ovaj lijek sadrži 0,50 mg aspartama u svakoj 5 mg raspadljivoj tableti za usta.
English: - The other ingredients are lactose monohydrate, powdered cellulose, pregelatinised maize starch, maize starch, colloidal anhydrous silica, magnesium stearate.
Croatian: - Pomoćne tvari su: laktoza hidrat, celuloza u prahu, prethodno geliran kukuruzni škrob,
English: Zalasta 7.5 mg tablets are: round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription 7.5.
Croatian: Zalasta tablete od 7,5 mg su: okrugle, blago bikonveksne, svijetlo žute tablete s mogućim pojedinačnim žutim mrljama i oznakom 7.5.
English: Each orodispersible tablet contains 7.5 mg olanzapine.
Croatian: Svaka raspadljiva tableta za usta sadrži 7,5 mg olanzapina.
English: Zalasta 10 mg orodispersible tablets Each orodispersible tablet contains 10 mg olanzapine.
Croatian: Zalasta 10 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 10 mg olanzapina.
English: Zalasta 15 mg orodispersible tablets EU/1/07/415/047-051
Croatian: Zalasta 15 mg raspadljive tablete za usta EU/1/07/415/047-051
English: Zalasta 7.5 mg orodispersible tablets Each orodispersible tablet contains 7.5 mg olanzapine.
Croatian: Zalasta 7,5 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 7,5 mg olanzapina.
English: Observed for fasting normal levels at baseline (< 5.56 mmol/l) which increased to high (≥ 7 mmol/l).
Croatian: Uočeno za početne normalne razine natašte (< 5,56 mmol/l) koje su porasle na visoke razine
English: Zalasta 5 mg orodispersible tablets Each orodispersible tablet contains 5 mg olanzapine.
Croatian: Zalasta 5 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 5 mg olanzapina.
English: Zalasta 7.5 mg orodispersible tablets EU/1/07/415/037-041
Croatian: Zalasta 7,5 mg raspadljive tablete za usta EU/1/07/415/037-041
English: Hypothermia
Croatian: Amnezija
English: BLISTER FOR ZALASTA 2.5 mg TABLETS
Croatian: BLISTER ZA ZALASTA 2,5 mg TABLETE
English: Zalasta 2.5 mg tablets Olanzapine
Croatian: Zalasta 2,5 mg tablete olanzapin
English: Mutagenicity
Croatian: Hipotermija
English: Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription “7.5”.
Croatian: Tablete su okrugle, blago bikonveksne, svijetlo žute s mogućim pojedinačnim žutim mrljama i utisnutom oznakom “7.5”.
English: Zalasta 5 mg tablets Olanzapine
Croatian: Zalasta 5 mg tablete olanzapin
English: Zalasta 20 mg tablets are: round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription 20.
Croatian: Zalasta tablete od 20 mg su: okrugle, blago bikonveksne, svijetlo žute tablete s mogućim pojedinačnim žutim mrljama i oznakom 20.
English: Zalasta 20 mg orodispersible tablets EU/1/07/415/052-056
Croatian: Zalasta 20 mg raspadljive tablete za usta EU/1/07/415/052-056
English: Changes in fasting glucose from borderline at baseline (≥ 5.56-< 7 mmol/l) to high (≥ 7 mmol/l) were very common.
Croatian: (≥ 5,56-< 7 mmol/l) do visokih vrijednosti (≥ 7 mmol/l) bile su vrlo česte.
English: Zalasta 10 mg orodispersible tablets EU/1/07/415/042-046
Croatian: Zalasta 10 mg raspadljive tablete za usta EU/1/07/415/042-046
English: Zalasta 2.5 mg tablets Zalasta 5 mg tablets Zalasta 7.5 mg tablets Zalasta 10 mg tablets Zalasta 15 mg tablets Zalasta 20 mg tablets
Croatian: Zalasta 2,5 mg tablete Zalasta 5 mg tablete Zalasta 7,5 mg tablete Zalasta 10 mg tablete Zalasta 15 mg tablete Zalasta 20 mg tablete
English: Zalasta 15 mg tablets Olanzapine
Croatian: Zalasta 15 mg tablete olanzapin
English: Each tablet contains 5 mg olanzapine.
Croatian: Svaka tableta sadrži 5 mg olanzapina.
English: BLISTER FOR ZALASTA 10 mg TABLETS
Croatian: BLISTER ZA ZALASTA 10 mg TABLETE
English: Zalasta 2.5 mg tablets Zalasta 5 mg tablets Zalasta 7.5 mg tablets Zalasta 10 mg tablets Zalasta 15 mg tablets Zalasta 20 mg tablets Olanzapine
Croatian: Zalasta 2,5 mg tablete Zalasta 5 mg tablete Zalasta 7,5 mg tablete Zalasta 10 mg tablete Zalasta 15 mg tablete Zalasta 20 mg tablete olanzapin
English: Each tablet contains 10 mg olanzapine.
Croatian: Svaka tableta sadrži 10 mg olanzapina.
English: Observed for fasting normal levels at baseline (< 5.17 mmol/l) which increased to high (≥ 6.2 mmol/l).
Croatian: Uočeno za početne normalne razine natašte (< 5,17 mmol/l) koje su porasle na visoke razine
English: Zalasta 10 mg tablets Olanzapine
Croatian: Zalasta 10 mg tablete olanzapin
English: Each orodispersible tablet contains 20 mg olanzapine.
Croatian: Svaka raspadljiva tableta za usta sadrži 20 mg olanzapina.
English: Hepatic impairment
Croatian: Otežano mokrenje
English: Zalasta 15 mg orodispersible tablets Each orodispersible tablet contains 15 mg olanzapine.
Croatian: Zalasta 15 mg raspadljive tablete za usta Svaka raspadljiva tableta za usta sadrži 15 mg olanzapina.
English: Zalasta 2.5 mg tablets Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots.
Croatian: Zalasta tablete od 2,5 mg su: okrugle, blago bikonveksne, svijetlo žute tablete s mogućim pojedinačnim žutim mrljama.
English: Zalasta 5 mg tablets Each tablet contains 80.9 mg lactose.
Croatian: Svaka tableta sadrži 80,9 mg laktoze.
English: Zalasta 5 mg orodispersible tablets EU/1/07/415/032-036
Croatian: Zalasta 5 mg raspadljive tablete za usta EU/1/07/415/032-036
English: Each tablet contains 15 mg olanzapine.
Croatian: Svaka tableta sadrži 15 mg olanzapina.
English: Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription “20”.
Croatian: Tablete su okrugle, blago bikonveksne, svijetlo žute s mogućim pojedinačnim žutim mrljama i utisnutom oznakom “20”.
English: BLISTER FOR ZALASTA 7.5 mg TABLETS
Croatian: BLISTER ZA ZALASTA 7,5 mg TABLETE
English: BLISTER FOR ZALASTA 7.5 mg ORODISPERSIBLE TABLETS
Croatian: BLISTER ZA ZALASTA 7,5 mg RASPADLJIVE TABLETE ZA USTA
English: Each orodispersible tablet contains 5 mg olanzapine.
Croatian: Svaka raspadljiva tableta za usta sadrži 5 mg olanzapina.
English: BLISTER FOR ZALASTA 20 mg ORODISPERSIBLE TABLETS
Croatian: BLISTER ZA ZALASTA 20 mg RASPADLJIVE TABLETE ZA USTA
English: EU/1/07/415/016 (7 tablets) EU/1/07/415/017 (14 tablets) EU/1/07/415/018 (28 tablets) EU/1/07/415/019 (35 tablets) EU/1/07/415/020 (56 tablets) EU/1/07/415/021 (70 tablets)
Croatian: EU/1/07/415/016 (7 tableta) EU/1/07/415/017 (14 tableta) EU/1/07/415/018 (28 tableta) EU/1/07/415/019 (35 tableta) EU/1/07/415/020 (56 tableta) EU/1/07/415/021 (70 tableta)
English: BLISTER FOR ZALASTA 15 mg TABLETS
Croatian: BLISTER ZA ZALASTA 15 mg TABLETE
English: Each orodispersible tablet contains 15 mg olanzapine.
Croatian: Svaka raspadljiva tableta za usta sadrži 15 mg olanzapina.
English: Tear.
Croatian: Otrgnite.
English: EU/1/07/415/006 (14 tablets) EU/1/07/415/007 (28 tablets) EU/1/07/415/008 (35 tablets) EU/1/07/415/009 (56 tablets) EU/1/07/415/010 (70 tablets)
Croatian: EU/1/07/415/006 (14 tableta) EU/1/07/415/007 (28 tableta) EU/1/07/415/008 (35 tableta) EU/1/07/415/009 (56 tableta) EU/1/07/415/010 (70 tableta)